Top

Breast Cancer Research and Treatment

Published in:

01-01-2020 | Epidemiology

Flat epithelial atypia: are we being too aggressive?

Authors: Ashley DiPasquale, Sveta Silverman, Erene Farag, Lashan Peiris

Published in: Breast Cancer Research and Treatment | Issue 2/2020

Abstract

Purpose

The malignant upgrade rate of flat epithelial atypia (FEA) diagnosed on core needle biopsy varies between 0 and 30%. Excision versus observation with radiological follow-up for these lesions remains controversial. We hypothesize that the local rate of FEA is low and that close radiological surveillance is a reasonable treatment option for patients diagnosed with pure FEA on breast needle core needle biopsy.

Methods

This study was a retrospective review of a prospectively collated provincial pathology database. Patients diagnosed with FEA alone on needle core biopsy between 2006 and 2016 were included in our analysis. Patients who had FEA present together with either in situ or invasive carcinoma within the same biopsy cores were excluded. Along with patient demographics, the size of the lesion on preoperative imaging, the method of extraction, and the presence of co-existing benign and malignant pathology on final excision biopsy were analyzed. An independent pathological review was performed to confirm our results and help reduce inter-observer bias.

Results

The local rate of malignant upgrade when pure FEA is diagnosed on a breast needle core biopsy is 12%. Age at time of diagnosis, size of original lesion on mammogram, presence of atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia on core needle biopsy, the use of vacuum-assisted biopsy (VAB), or concordant imaging did not significantly correlate with malignant upgrade risk. None of the patients who were managed with radiological follow-up had malignant upgrade during follow-up. Patients undergoing radiological follow-up alone were more likely to have a VAB, concordant imaging, and no concurrent ADH.

Conclusion

Our local malignant upgrade rate is consistent with published literature. We suggest radiological follow-up is a safe alternative in patients with pure flat epithelial atypia and concordant imaging, particularly those patients with small lesions in which microcalcifications can be removed completely with vacuum-assisted biopsy.

Chi-Shern HB, Hoon TP (2005) Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology 37(2):105–111. https://doi.org/10.1080/00313020500058532 CrossRef

Hanby A, Walker C, Tavassoli FA, Devilee P (2004) Pathology and genetics: tumours of the breast and female genital organs. WHO classification of tumours series, vol 4. IARC Press, Lyon. https://doi.org/10.1186/bcr788 CrossRef

Simpson P, Gale T, Reis-Filho J et al (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? Am J Surg Pathol 29(6):734–746. https://doi.org/10.1097/01.pas.0000157295.93914.3b CrossRefPubMed

Reis-Filho J, Simpson P, Gale T, Lakhani S (2005) The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 201(11):713–725. https://doi.org/10.1016/j.prp.2005.05.013 CrossRefPubMed

Goldstein N, O’Malley B (1997) Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol 107(5):561–566. https://doi.org/10.1093/ajcp/107.5.561 CrossRefPubMed

Oyama T, Maluf H, Koerner F (1999) Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ. Virchows Arch 435(4):413–421. https://doi.org/10.1007/s004280050419 CrossRefPubMed

Eusebi V, Feudale E, Foschini MP, Micheli A, Conti A, Riva C, DiPalma S, Rilke F (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11(3):223–235PubMed

Wisell J (2010) flat epithelial atypia on core needle biopsy: which is the right management? Yearb Pathol Lab Med 2010:26–27. https://doi.org/10.1016/s1077-9108(09)79426-5 CrossRef

Martel M, Barron-Rodriguez P, Tolgay-Ocal I, Dotto J, Tavassoli F (2007) Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992–1999). Virchows Arch 451(5):883–891. https://doi.org/10.1007/s00428-007-0499-z CrossRefPubMed

10.

Becker A, Gordon P, Harrison D et al (2013) Flat ductal intraepithelial neoplasia 1A diagnosed at stereotactic core needle biopsy: is excisional biopsy indicated? Am J Roentgenol 200(3):682–688. https://doi.org/10.2214/ajr.11.8090 CrossRef

11.

Senetta R, Campanino P, Mariscotti G et al (2009) Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic and histological correlations. Mod Pathol 22(6):762–769. https://doi.org/10.1038/modpathol.2009.21 CrossRefPubMed

12.

World Medical Association (WMA) (2009) Declaration of Helsinki. Ethical principles for medical research involving human subjects. Jahrb Wiss Ethik. https://doi.org/10.1515/9783110208856.233 CrossRef

13.

Chan P, Chotai N, Lai E et al (2018) Majority of flat epithelial atypia diagnosed on biopsy do not require surgical excision. Breast 37:13–17. https://doi.org/10.1016/j.breast.2017.10.005 CrossRefPubMed

14.

Lavoué V, Roger C, Poilblanc M et al (2010) Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision. Breast Cancer Res Treat 125(1):121–126. https://doi.org/10.1007/s10549-010-1208-1 CrossRefPubMed

15.

Bianchi S, Bendinelli B, Castellano I et al (2012) Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision. Virchows Arch 461(4):405–417. https://doi.org/10.1007/s00428-012-1279-y CrossRefPubMed

16.

Ingegnoli A, Aloia C, Frattaruolo A et al (2010) Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate. Breast J 16(1):55–59. https://doi.org/10.1111/j.1524-4741.2009.00850.x CrossRefPubMed

17.

Peres A, Barranger E, Becette V, Boudinet A, Guinebretiere J, Cherel P (2011) Rates of upgrade to malignancy for 271 cases of flat epithelial atypia (FEA) diagnosed by breast core biopsy. Breast Cancer Res Treat 133(2):659–666. https://doi.org/10.1007/s10549-011-1839-x CrossRefPubMed

18.

Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2016) Canadian Cancer Statistics 2016. Canadian Cancer Society, Toronto

19.

David N, Labbe-Devilliers C, Moreau D, Loussouarn D, Campion L (2007) Diagnosis of flat epithelial atypia after stereotactic vacuum-assisted biopsy of the breast: what is the best management: systematic surgery for all or follow-up? Clin Imaging 31(3):221. https://doi.org/10.1016/j.clinimag.2007.02.011 CrossRef

20.

Boulos F, Dupont W, Schuyler P et al (2011) Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions. Cancer 118(9):2372–2377. https://doi.org/10.1002/cncr.26523 CrossRefPubMed

21.

Schiaffino S, Gristina L, Villa A, Tosto S, Monetti F, Carli F, Calabrese M (2018) Flat epithelial atypia: conservative management of patients without residual microcalcifications post-vacuum-assisted breast biopsy. Br J Radiol 91(1081):20170484. https://doi.org/10.1259/bjr.20170484 CrossRefPubMed

22.

Calhoun BC, Sobel A, White RL, Gromet M, Flippo T, Sarantou T, Livasy CA (2015) Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies. Mod Pathol 28(5):670–676. https://doi.org/10.1038/modpathol.2014.159 CrossRefPubMed

23.

Hartmann L, Radisky D, Frost M et al (2014) Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res 7(2):211–217. https://doi.org/10.1158/1940-6207.capr-13-0222 CrossRef

24.

Page D, Schuyler P, Dupont W, Jensen R, Plummer W, Simpson J (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 361(9352):125–129. https://doi.org/10.1016/s0140-6736(03)12230-1 CrossRefPubMed

25.

Ferrini R, Mannino E, Ramsdell E, Hill L (1996) Screening mammography for breast cancer: American College of preventive medicine practice policy statement. Am J Prev Med 12(5):340–341CrossRef

26.

Hugar SB, Bhargava R, Dabbs DJ, Davis KM, Zuley M, Clark BZ (2019) Isolated flat epithelial atypia on core biopsy specimens is associated with a low risk of upgrade at excision. Am J Clin Pathol 151(5):511–515. https://doi.org/10.1093/ajcp/aqy175 CrossRefPubMed

27.

McCroskey Z, Sneige N, Herman CR, Miller RA, Venta LA, Ro JY, Schwartz MR, Ayala AG (2018) Flat epithelial atypia in directional vacuum-assisted biopsy of breast microcalcifications: surgical excision may not be necessary. Mod Pathol 31:1097–1106CrossRef

Title: Flat epithelial atypia: are we being too aggressive?
Authors: Ashley DiPasquale
Sveta Silverman
Erene Farag
Lashan Peiris
Publication date: 01-01-2020
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05481-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2020

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study

Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”

Keynote webinar | Spotlight on antibody–drug conjugates in cancer